Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - CASH & EQUIVALENTS
Cash & Equivalents ALLO - Allogene Therapeutics, Inc.
83.2 M
LAST VALUE
-67.95%
2 YEAR CAGR
-35.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR